MOLLY GIBBS
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care WASHINGTON, DC NPI 1942880331
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care DC Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$2,082.91
- Category: General Payments
- Program years: PY2023–2024
- Record count: 49
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,696.38 across 43 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,612.39 | 42 |
| Education | $83.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $252.81 | 4 |
| Teleflex LLC | $176.87 | 4 |
| Incyte Corporation | $169.88 | 3 |
| Daiichi Sankyo Inc. | $142.46 | 8 |
| Gilead Sciences, Inc. | $136.50 | 1 |
| Rigel Pharmaceuticals, Inc. | $126.50 | 1 |
| ABBVIE INC. | $87.39 | 1 |
| E.R. Squibb & Sons, L.L.C. | $74.70 | 2 |
| Alexion Pharmaceuticals, Inc. | $73.70 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $73.38 | 1 |
| Genentech USA, Inc. | $43.97 | 2 |
| Merck Sharp & Dohme Corporation | $43.73 | 2 |
| Stemline Therapeutics Inc. | $41.07 | 1 |
| Lilly USA, LLC | $40.92 | 2 |
| EISAI INC. | $32.10 | 1 |
| Coherus Biosciences Inc. | $29.83 | 1 |
| Celgene Corporation | $29.17 | 1 |
| JAZZ PHARMACEUTICALS INC. | $28.69 | 1 |
| GlaxoSmithKline, LLC. | $26.28 | 1 |
| Genmab U.S., Inc. | $23.57 | 1 |
| Exelixis Inc. | $21.97 | 1 |
| SOBI, INC | $20.89 | 1 |
By program year
Records — PY2024 (43)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.